| 2024/05/22 22:00:00 | |
|---|---|
| Price | |
| 107.39 USD | |
| Difference | -0.20% (-0.22) |
General attributes
| ISIN | US4523271090 |
| Symbol | ILMN |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 15,804 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 107.00 USD (100) |
| Ask (Ask size) | 107.39 USD (300) |
| Open | 106.93 USD |
| High | 109.69 USD |
| Low | 106.00 USD |
| Close (prev. day) | 107.61 USD |
| VWAP | 107.920282 USD |
| Volume (pcs) | 1,654,946 |
| Trading volume | 178,688,695.90 |
| Number of trades | 31,358 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: ILLUMINA INC. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/22 22:00:00 | |
|---|---|
| Price | |
| 107.39 USD | |
| Difference | -0.20% (-0.22) |
General attributes
| ISIN | US4523271090 |
| Symbol | ILMN |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 15,804 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 107.00 USD (100) |
| Ask (Ask size) | 107.39 USD (300) |
| Open | 106.93 USD |
| High | 109.69 USD |
| Low | 106.00 USD |
| Close (prev. day) | 107.61 USD |
| VWAP | 107.920282 USD |
| Volume (pcs) | 1,654,946 |
| Trading volume | 178,688,695.90 |
| Number of trades | 31,358 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +9.85% | -48.58% | -73.06% |
| Perf (abs.) | +9.63 | -101.46 | -291.23 |
| Beta | 1.49 | 1.27 | 1.38 |
| Volatility | 41.89 | 41.36 | 45.95 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 109.81 USD (1,490,543) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 117.70 USD (1,583,830) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 131.13 USD (1,713,156) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 144.30 USD (1,904,458) |
| YTD High | date | 148.19 USD (2024/01/31) |
| YTD Low | date | 106.00 USD (2024/05/22) |
| 52 Weeks High | date | 213.91 USD (2023/05/24) |
| 52 Weeks Low | date | 89.00 USD (2023/11/10) |
All listings for ILLUMINA INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Berlin | 2024/05/22 | 08:08 | 98.87 EUR | 0.00 | 2 |
| Duesseldorf | 2024/05/22 | 19:31 | 100.18 EUR | 0.00 | 7 |
| Euronext Milan MTF Global Equity Market | 2024/05/22 | 17:44 | 99.72 EUR | 0.05 | 7 |
| Euronext Milan MTF Trading After Hours | - | - | - | 0.00 | - |
| Frankfurt | 2024/05/22 | 21:50 | 98.66 EUR | 0.00 | 1 |
| Hanover | 2024/05/22 | 08:14 | 98.52 EUR | 0.00 | 3 |
| London Stock Exchange | 2024/05/09 | 15:30 | 110.85 USD | 0.00 | 1 |
| Munich | 2024/05/22 | 08:01 | 98.53 EUR | 0.00 | 2 |
| Nasdaq | 2024/05/22 | 22:00 | 107.39 USD | 178.69 | 31,358 |
| Stuttgart | 2024/05/22 | 18:58 | 100.02 EUR | 0.00 | 7 |
| Tradegate | 2024/05/22 | 22:26 | 99.22 EUR | 0.09 | 21 |
| Vienna Stock Exchange | 2024/05/22 | 17:32 | 100.04 EUR | 0.00 | 2 |
| Xetra | 2024/05/22 | 17:35 | 99.89 EUR | 0.02 | 10 |
Company Logo
Contact Details
| ILLUMINA INC. |
| - - |
| 5200 Illumina Way - 92122 San Diego |
| Telefon: +1-858-202-4500 |
| Fax: +1-858-202-4545 |
| E-mail: info@illumina.com |
PDF Downloads
| Company report: ILLUMINA INC. | |
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA. |
Members of Management Board
| Stephen MacMillan | Chairman of Board of Directors |
| Frances Arnold | Member of Board of Directors |
| Gary Guthart | Member of Board of Directors |
| Robert Epstein | Member of Board of Directors |
| Scott Gottlieb | Member of Board of Directors |
| Caroline Dorsa | Member of Board of Directors |
| Philip Schiller | Member of Board of Directors |
| Scott Ullem | Member of Board of Directors |
| Susan Siegel | Member of Board of Directors |
| Jacob Thaysen | Chairman of Managing Board |
| Carissa Rollins | Member of Executive Committee |
| Joydeep Goswami | Member of Executive Committee |
| Kathryne Reeves | Member of Executive Committee |
| Steve Barnard | Member of Executive Committee |